Veliparib PARP inhibitor investigational

Indicated For

Ovarian cancer, breast cancer, glioblastoma, non-small cell lung cancer

About This Medication

# myAbbVie Assist Patient Guide: How to Get Veliparib at Low or No Cost **Important Notice:** Veliparib (also known as ABT-888) is an investigational oral PARP inhibitor developed by AbbVie. It is **not FDA-approved** for any use and is only available through clinical trials or compassionate use programs, if applicable. There is no dedicated patient assistance program (PAP) specifically for veliparib because it is not commercially available. However, AbbVie's **myAbbVie Assist** program provides free AbbVie medicines to eligible patients who lack insurance coverage or cannot afford their medications. This guide explains how myAbbVie Assist works, potential eligibility for investigational drugs like veliparib (if offered), and steps to explore access options.[3] Always consult your doctor for the latest trial opportunities. ## About Veliparib Veliparib is an experimental drug studied in combination with chemotherapy (like carboplatin and paclitaxel) or radiation to treat various cancers by inhibiting PARP, an enzyme that helps cancer cells repair DNA damage.[1][2][5] It has been evaluated in Phase 3 trials for: - **HER2-negative metastatic breast cancer** with BRCA1/2 mutations.[1] - **Advanced squamous non-small cell lung cancer (NSCLC)** (received FDA Orphan Drug Designation).[2][6] - **High-grade serous ovarian, fallopian tube, or primary peritoneal cancer**.[4] - **Triple-negative breast cancer** and other solid tumors.[5][7] **Key Facts:** - Veliparib is taken orally, typically 150-400 mg twice daily in trials.[4] - Phase 3 studies did not meet primary endpoints for some indications, but research continues in others like myelofibrosis (Phase 2).[5][9] - As of 2026, it remains investigational—no commercial approval.[1][2][5] **Why This Matters:** If you're prescribed veliparib through a trial, costs may be covered by the sponsor. For non-trial access, myAbbVie Assist could apply if AbbVie expands support. ## Who Qualifies for myAbbVie Assist? myAbbVie Assist helps U.S. patients (age 18+) get free AbbVie drugs if they: - Have no prescription drug coverage (uninsured) **or** limited coverage with high out-of-pocket costs. - Live in the U.S. or U.S. territories. - Meet **income guidelines** (400% of Federal Poverty Level or lower—see table below). **Note for Veliparib:** Since it's investigational, eligibility depends on AbbVie offering it via the program. Check with your doctor or AbbVie for trial enrollment first.[3] ## Income Eligibility Breakdown Eligibility is based on household income and size. Limits adjust annually; use 2026 estimates (verify at application). | Household Size | Annual Income Limit (400% FPL) | |----------------|-------------------------------| | 1 | $60,240 | | 2 | $81,760 | | 3 | $103,280 | | 4 | $124,800 | | 5 | $146,320 | | +1 person | +$21,520 | **Examples:** A single person earning $50,000/year qualifies; a family of 4 at $120,000 does. Include all income sources (tax returns required). No asset test.[3] ## Insurance Requirements - **Uninsured patients:** Fully eligible if income-qualified. - **Insured patients:** Eligible if insurance denies coverage **or** copays exceed affordability (e.g., >$50/month). Medicare Part D patients often qualify if in the "coverage gap" (donut hole). - **Medicaid:** Generally ineligible, but exceptions for high copays. - **For Veliparib:** Trial participants typically have costs covered; myAbbVie Assist may bridge gaps post-trial if approved. **Pro Tip:** Submit proof of insurance denial or Explanation of Benefits (EOB) form.[3] ## Step-by-Step Application Process 1. **Confirm Eligibility:** Use the myAbbVie Assist prescreener online or call 1-800-222-6885.[3] 2. **Gather Documents:** See "Required Documents" section below. 3. **Get Doctor's Help:** Your physician completes the application, certifying medical need. 4. **Apply:** Download form from myAbbVieAssist.com, mail/fax, or apply online/phone.[3] 5. **Wait for Approval:** Processing takes 2-4 weeks. 6. **Receive Medication:** Shipped to doctor's office or home. **Application Contacts:** - Phone: 1-800-222-6885 - Website: myAbbVieAssist.com - Hours: Mon-Fri, 8 AM-6 PM ET ## Timeline and Delivery - **Processing:** 2-4 weeks from receipt of complete application.[3] - **Approval Notice:** Mailed/emailed; track status online. - **Delivery:** Free shipping to your doctor's office (preferred) or home. Up to 3-month supply per shipment. - **For Veliparib:** If available, similar timeline; trial drugs ship directly from sponsor. ## Required Documents - Proof of income (last year's tax return, W-2, pay stubs, SSI/SSD award letter). - Proof of residency (utility bill, lease). - Insurance info/EOB/denial letter. - Photo ID. - Doctor's prescription and application section.[3] ## Reauthorization and Refills Annual renewal required. Your doctor resubmits; program sends reminders. Covers up to 12 months.[3] ## Alternatives if Denied or Ineligible - **Clinical Trials:** Search ClinicalTrials.gov for veliparib (e.g., NCT02470585).[4] - **Other PAPs:** NeedyMeds.org or RxAssist.org for similar drugs.[3] - **Manufacturer Compassionate Use:** Contact AbbVie Medical Information (1-800-633-9110). - **Financial Aid:** CancerCare.org, Patient Access Network (PAN) Foundation. - **Biosimilars/Alternatives:** No biosimilars for veliparib (investigational). Other PARP inhibitors like olaparib (Lynparza) have PAPs if BRCA+.[1][2] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Veliparib is **not approved** by the FDA and unavailable commercially—no guaranteed PAP access.[1][2][5] Eligibility/rules change; verify with myAbbVie Assist. Not medical/financial advice—consult your healthcare provider. AbbVie reserves rights to modify program.[3] Word count: 950.

Program information last verified: March 30, 2026